The past, present and future role of the dopamine D2 receptor in schizophrenia

被引：0
|
作者：
Kapur, S. [1 ]
机构：
[1] Kings Coll London, Psychosis Studies Inst Psychiat, London WC2R 2LS, England
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2010年 / 20卷
关键词：
D-2; ANTIPSYCHOTICS;
D O I：
10.1016/S0924-977X(10)70125-5
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S163 / S164
页数：2
相关论文
共 50 条
  • [1] The past, present and future role of the dopamine D2 receptor in Schizophrenia
    Kapur, Shitij
    INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE, 2011, 15 : 5 - 5
  • [2] History of the Discovery of the Antipsychotic Dopamine D2 Receptor: A Basis for the Dopamine Hypothesis of Schizophrenia
    Madras, Bertha K.
    JOURNAL OF THE HISTORY OF THE NEUROSCIENCES, 2013, 22 (01) : 62 - 78
  • [3] Dopamine D2 receptor partial agonists in the treatment of schizophrenia - example of brexpiprazole
    Blizniewska-Kowalska, Katarzyna
    Galecki, Piotr
    PSYCHIATRIA POLSKA, 2024, 58 (04) : 581 - 593
  • [4] New Concepts in Dopamine D2 Receptor Biased Signaling and Implications for Schizophrenia Therapy
    Urs, Nikhil M.
    Peterson, Sean M.
    Caron, Marc G.
    BIOLOGICAL PSYCHIATRY, 2017, 81 (01) : 78 - 85
  • [5] No Evidence for an Association between Dopamine D2 Receptor Polymorphisms and Tardive Dyskinesia in Korean Schizophrenia Patients
    Park, Young-Min
    Kang, Seung-Gul
    Choi, Jung-Eun
    Kim, Yong-Ku
    Kim, Seung-Hyun
    Park, Ji-Young
    Kim, Leen
    Lee, Heon-Jeong
    PSYCHIATRY INVESTIGATION, 2011, 8 (01) : 49 - 54
  • [6] Potent Dopamine D2 Receptor Antagonists Block the Reward-Enhancing Effects of Nicotine in Smokers With Schizophrenia
    Whitton, Alexis
    Green, Alan
    Pizzagalli, Diego
    Williams, Jill
    Brunette, Mary
    BIOLOGICAL PSYCHIATRY, 2018, 83 (09) : S443 - S443
  • [7] Tardive dyskinesia in relation to estimated dopamine D2 receptor occupancy in patients with schizophrenia: Analysis of the CATIE data
    Yoshida, Kazunari
    Bies, Robert R.
    Suzuki, Takefumi
    Remington, Gary
    Pollock, Bruce G.
    Mizuno, Yuya
    Mimura, Masaru
    Uchida, Hiroyuki
    SCHIZOPHRENIA RESEARCH, 2014, 153 (1-3) : 184 - 188
  • [8] D2 partial agonists: their pharmacology and potential role in schizophrenia
    Agid, O.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2017, 27 : S1137 - S1138
  • [9] Correlation between fine motor activity and striatal dopamine D2 receptor density in patients with schizophrenia and healthy controls
    Yang, YK
    Chiu, NT
    Chen, CC
    Chen, M
    Yeh, TL
    Lee, IH
    PSYCHIATRY RESEARCH-NEUROIMAGING, 2003, 123 (03) : 191 - 197
  • [10] Therapeutic Window for Striatal Dopamine D2/3 Receptor Occupancy in Older Patients with Schizophrenia: A Pilot PET Study
    Uchida, Hiroyuki
    Suzuki, Takefumi
    Graff-Guerrero, Ariel
    Mulsant, Benoit H.
    Pollock, Bruce G.
    Arenovich, Tamara
    Rajji, Tarek K.
    Mamo, David C.
    AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2014, 22 (10) : 1007 - 1016
12345